The decision to discontinue SerpinPC follows the approval of Hympavzi, an antibody-based treatment designed to increase ...

A delayed diagnosis is common for people with acquired hemophilia A (AHA), according to a new study that found that it took ...

A Summerville man became the first person in South Carolina to undergo potentially life-changing gene therapy. The treatment took place Thursday morning at Prisma Health's Hemophilia Treatment Center ...

Friday Headlines: 38 y/o Brent Maloy is the first person in SC to undergo gene therapy treatment after living with Hemophilia ...

The CDC estimates about 10 in 100,000 people have hemophilia A. • Hemophilia B: Hemophilia B happens when you don’t have enough clotting factor 9 (factor IX.) The CDC estimates about 3 in ...

As many as 30% of people living with severe hemophilia A develop inhibitors such as TFPI, which can be produced by the body’s immune response to clotting factors in replacement therapy, often limiting ...

Haemophilia is a rare bleeding disorder that mostly occurs in men An expert explains why and shares ways to reduce the risk ...

“That interview reached the executive director of the New York Hemophilia chapter, and he asked me to perform at an event at ...

The gene therapy improved annualized bleed rates, though a handful of study participants resumed factor IX prophylaxis.